Balo-at, Shaed A.

HRN: 25-35-38  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2025
CEFUROXIME 1.5GM (VIAL)
10/25/2025
10/31/2025
IV
800mg
Q8
URTI
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: